Biotech RadarJobs updated

COMPANY

Dianthus Therapeutics

HQ: New York, NY source · dianthustx.com ↗

Clinical Phase 3

6 open jobs · last seen Oct 23, 2026 · 5 sources

Keywords: immunology autoimmune diseases subcutaneous Generalized Myasthenia Gravis Chronic Inflammatory Demyelinating Polyneuropathy Multifocal Motor Neuropathy Claseprubart

Location: New York, NY · source · Oct 14, 2026

Profile checked Oct 10, 2026

6Open jobs4Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Senior Medical Science Liaison (Neurology) Northeast or Midwest RegionRemoteOct 9, 2026Oct 9, 2026
Senior Medical Science Liaison (Neurology); West RegionRemoteOct 9, 2026Oct 9, 2026
Executive Director, Head of Bioanalytical SciencesRemoteOct 2, 2026Oct 9, 2026
Associate Director/Director, Clinical Pharmacology and PharmacometricsRemoteAug 19, 2026Oct 9, 2026
Associate Director, Clinical OperationsRemoteAug 19, 2026Oct 9, 2026

See all 6 jobs

Timeline

  1. Board tracked Radar started tracking this company’s job board (6 open jobs at last check). source ↗
  2. Trial start 3: A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE) source ↗
  3. Trial start Phase 3: A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) source ↗
  4. Trial start Phase 2: A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy source ↗
  5. Trial start 2: A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 6

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Senior Medical Science Liaison (Neurology) Northeast or Midwest RegionRemoteOct 9, 2026Oct 9, 2026Senior
Senior Medical Science Liaison (Neurology); West RegionRemoteOct 9, 2026Oct 9, 2026Senior
Executive Director, Head of Bioanalytical SciencesRemoteOct 2, 2026Oct 9, 2026Executive
Associate Director/Director, Clinical Pharmacology and PharmacometricsRemoteAug 19, 2026Oct 9, 2026Senior
Associate Director, Clinical OperationsRemoteAug 19, 2026Oct 9, 2026Senior
Associate Director/Director Drug Product, CMCRemoteJul 6, 2026Oct 9, 2026Senior

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT06858579A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)Phase 3RecruitingFeb 10, 2025Dec 31, 2028 (estimated)
NCT07647510A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)3RecruitingJun 29, 20262028-12 (estimated)
NCT06537999A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyPhase 2Active, not recruitingSep 17, 20242026-12 (estimated)
NCT06282159A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)2Active, not recruitingFeb 23, 2024Jul 28, 2025 (actual)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Connect

See your connections at Dianthus Therapeutics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback